“Palbociclib plus endocrine therapy in Premenopausal women in HR+/Her2- Breast Cancer with Visceral Metastases versus Combined Chemotherapy” (2025) Journal of Carcinogenesis, 24(3), pp. 635–642. doi:10.64149/J.Carcinog.24.3.635-642.